Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Italy and Switzerland registers with The Mediterranean Institute for Transplantation and Advanced Specialized Therapies as lead sponsor. Synced 16 Nov 2026
5Current trials
3Recruiting now
0Drugs in these trials
2Trial registers
At a glance

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies is the lead sponsor of 5 current clinical trials in our Italy and Switzerland registers. 3 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Liver Transplantation (LT).

ClinicalTrials.gov trials by status

  • Recruiting360%
  • Not yet open120%
  • By invitation120%

Trials by phase

  • Not applicable360%
  • Observational120%
  • Phase 3120%
01

Clinical trials sponsored by The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

5 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation
NCT07692490 · ClinicalTrials.gov ↗ · Liver Transplantation (LT), Ischemia-Reperfusion Injury, Early Allograft Dysfunction
Not applicable Recruiting 2026-07 Italy
Multidisciplinary Non-Pharmacological Intervention to Improve Quality of Life in Solid Organ Transplant Recipients
NCT07870811 · ClinicalTrials.gov ↗ · Heart Transplant Patients, Kidney Transplant Patients, Lung Transplant
Not applicable Recruiting 2026-04 Italy
Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients With Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome
NCT06814626 · ClinicalTrials.gov ↗ · Liver Cirrhosis, Refractory Ascites in Patients With Cirrhosis, Sarcopenia in Liver Cirrhosis
Phase 3 Recruiting 2022-10 Italy, Switzerland
New Biomarkers for Organ Viability Assessment During Hypothermic Machine Perfusion in Liver Transplantation: the Role of Extemporaneous Histological Examination.
NCT07674394 · ClinicalTrials.gov ↗ · Liver Transplantation (LT), Early Allograft Dysfunction, Primary Non-function
Not applicable Not yet open 2026-12 Italy
Italian Lung Cancer Observational Study
NCT05851755 · ClinicalTrials.gov ↗ · Lung Cancer
Observational By invitation 2023-04 Italy

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in The Mediterranean Institute for Transplantation and Advanced Specialized Therapies trials

12 conditions
Liver Transplantation (LT)2Ischemia-Reperfusion Injury2Early Allograft Dysfunction2Lung Cancer1Heart Transplant Patients1Kidney Transplant Patients1Lung Transplant1Liver Transplanted Patients1Primary Non-function1Liver Cirrhosis1Refractory Ascites in Patients With Cirrhosis1Sarcopenia in Liver Cirrhosis1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Italy53
Clinical trials in Switzerland11

A trial with sites in more than one country appears in each of those registers.

04

Questions about The Mediterranean Institute for Transplantation and Advanced Specialized Therapies trials

How many clinical trials does The Mediterranean Institute for Transplantation and Advanced Specialized Therapies sponsor?

The Mediterranean Institute for Transplantation and Advanced Specialized Therapies is the lead sponsor of 5 current trials on ClinicalTrials.gov in our Italy and Switzerland registers, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.

Are The Mediterranean Institute for Transplantation and Advanced Specialized Therapies trials recruiting?

Yes. 3 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.